Cognito Therapeutics
MA - CambridgeBiotechnology
Focus: Cognito Therapeutics is a public-stage biotechnology company focused on device-based brain therapies, headquartered in Cambridge, MA with a concentrated focus on Alzheimer's disease treatment through non-pharmacological stimulation systems.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Cognito Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Cognito Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Cognito Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
GammaSense Stimulation System
Alzheimer DiseaseClinical Trials (1)
NCT03556280Multi-Center Study of Sensory Stimulation to Improve Brain Function
N/AHelp build intelligence for Cognito Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.